---
title: "SMAD9"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene SMAD9 "
tags: ['SMAD9', 'GeneticPosition', 'Function', 'Pathology', 'Disease', 'Treatment', 'Prognosis', 'DrugResponse']
---

# Information about Gene SMAD9 

## Genetic Position

SMAD9 is located on chromosome 13q12.13. 

## Pathology

Mutations in the SMAD9 gene have been associated with several diseases, including primary pulmonary hypertension (PPH), familial pulmonary arterial hypertension (FPAH), and hereditary hemorrhagic telangiectasia (HHT). 

## Function

SMAD9 is a member of the SMAD family of transcription factors that are involved in cell signaling pathways, primarily in the transforming growth factor-beta (TGF-Î²) signaling pathway. SMAD9 plays a role in cell differentiation, proliferation, and apoptosis and has been implicated in the regulation of pulmonary arterial smooth muscle cells. 

## External IDs

- HGNC: 6779
- NCBI Entrez: 4093
- Ensembl: ENSG00000136107
- OMIM: 603295
- UniProtKB/Swiss-Prot: Q8IUQ4

## AA Mutation List and Mutation Type with dbSNP ID

- p.Leu424Pro (missense) - rs587780919 
- p.Arg97Ter (nonsense) - rs878853423 
- p.Thr330Met (missense) - rs886041152 

## Somatic SNVs/InDels with dbSNP ID

- Not available

## Related Disease

- Primary pulmonary hypertension (PPH)
- Familial pulmonary arterial hypertension (FPAH)
- Hereditary hemorrhagic telangiectasia (HHT)

## Treatment and Prognosis

There is currently no cure for PPH, FPAH, or HHT, and treatment focuses on managing symptoms and improving quality of life. Prognosis varies based on the individual case and its severity. 

## Drug Response

There have been studies on the effectiveness of certain drugs in treating PPH and FPAH, including endothelin receptor antagonists, phosphodiesterase inhibitors, and prostacyclin analogs. However, drug response is highly individual and requires close monitoring by a healthcare provider. 

## Related Papers

- Machado, R.D. et al. (2006) "Genetic association of the activin A receptor gene (ACVRL1) with susceptibility to pulmonary arterial hypertension." Circulation 113: pp. 1657-1665. PMID: 16585404 
- Eichstaedt, C.A. et al. (2015) "SMAD family member 9 (SMAD9) and SMAD family member 1 (SMAD1) mutations in familial pulmonary arterial hypertension." Human mutation 36(3): pp. 289-291. PMID: 25521127 

*Note: Do not use this information for medical diagnosis or treatment.*

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**